Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors - Data from the German PRAEGNANT breast cancer registry (2018) Hartkopf AD, Huober J, Volz B, Nabieva N, Taran FA, Schwitulla J, Overkamp F, et al. Journal article Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registry (2018) Mueller V, Nabieva N, Häberle L, Taran FA, Hartkopf AD, Volz B, Overkamp F, et al. Journal article Budget impact analysis of gene expression tests to aid therapy decisions for breast cancer patients in Germany (2018) Lux MP, Nabieva N, Hildebrandt T, Rebscher H, Kummel S, Blohmer JU, Schrauder MG Journal article Anti-Müllerian hormone (AMH) levels in premenopausal breast cancer patients treated with taxane-based adjuvant chemotherapy - A translational research project of the SUCCESS A study (2017) Trapp E, Steidl J, Rack B, Kupka MS, Andergassen U, Jueckstock J, Kurt A, et al. Journal article Comparative budget impact assessment of the different breast cancer genomic tests in Germany (2017) Lux MP, Schrauder MG, Hildebrandt T, Nabieva N, Kuemmel S, Blohmer JU Conference contribution Cost-effectiveness of risk-reducing surgeries in preventing hereditary breast and ovarian cancer (2017) Schrauder MG, Brunel-Geuder L, Häberle L, Wunderle M, Hoyer J, Wiesmann da Silva Reis A, Schulz-Wendtland R, et al. Journal article The effects of tamoxifen on radiation-induced pulmonary fibrosis in Wistar albino rats: Results of an experimental study (2006) Bese NS, Umay C, Yildirim S, Ilvan S, Dirican A, Salar S, Altug T, Ober A Journal article